Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients-Reference-Cited by-同舟云学术

Is diabetic hypercoagulability an acquired annexinopathy? Glycation of annexin II as a putative mechanism for impaired fibrinolysis in diabetic patients

Published:2002-09 Issue:3 Volume:59 Page:247-251
ISSN:0306-9877
Container-title:Medical Hypotheses
language:en
Short-container-title:Medical Hypotheses

Author:

Gugliucci A,Ghitescu L

Publisher

Elsevier BV

Subject

General Medicine

Reference38 articles.

1. Type 2 diabetes: one disease, multiple cardiovascular risk factors;Calles-Escandon;Coron. Artery Dis.,1999

2. The UK prospective diabetes study. A review;Turner;Diabetes Care,1998

3. Results of the DCCT trial. Implications for managing our patients with diabetes;Worrall;Can Fam. Physician,1994

4. A review of the United Kingdom Prospective Diabetes Study (UKPDS) and a discussion of the implications for patient care;Srimanunthiphol;Hawaii Med. J.,2000

5. Cardiovascular risk in diabetes: a brief review;Marks;J. Diabetes Complications,2000

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Multiomics Analysis–Based Biomarkers in Diagnosis of Polycystic Ovary Syndrome;Reproductive Sciences;2022-01-27

2. Diabetes Mellitus/Poststroke Hyperglycemia: a Detrimental Factor for tPA Thrombolytic Stroke Therapy;Translational Stroke Research;2020-11-02

3. The role of advanced glycation end-products in the development of coronary artery disease in patients with and without diabetes mellitus: a review;Molecular Medicine;2018-11-23

4. Overlap of proteomics biomarkers between women with pre-eclampsia and PCOS: a systematic review and biomarker database integration;Human Reproduction;2014-10-28

5. MECHANISMS IN ENDOCRINOLOGY: Proteomic biomarkers of type 2 diabetes mellitus risk in women with polycystic ovary syndrome;European Journal of Endocrinology;2013-02